GSK (NYSE:GSK) reported quarterly earnings of $0.68 per share which beat the analyst consensus estimate of $0.64 by 6.25 percent. This is a 17.24 percent increase over earnings of $0.58 per share from the same period last year. The company reported quarterly sales of $11.460 billion which beat the analyst consensus estimate of $11.190 billion by 2.41 percent. This is a 13.86 percent increase over sales of $10.065 billion the same period last year.